Prestigio Ltd. (DermaZor)

About

Q&A

What is Prestigio Ltd. (DermaZor)'s primary focus?

Prestigio Ltd. (DermaZor) is an Israeli dermatology-specialist company focused on the research and development of pharmaceutical products for damaged skin and skin diseases, particularly psoriasis.

What is the flagship product of Prestigio Ltd. (DermaZor)?

The flagship product of Prestigio Ltd. (DermaZor) is DermaZor, a patented, FDA OTC listed, cannabis-enriched cream for the treatment of psoriasis and seborrheic dermatitis.

When was Prestigio Ltd. (DermaZor) founded?

Prestigio Ltd. (DermaZor) was founded in 2013.

Where is Prestigio Ltd. (DermaZor) headquartered?

Prestigio Ltd. (DermaZor) is headquartered in Yehud, Israel.

What are the key technologies utilized by Prestigio Ltd. (DermaZor)?

Prestigio Ltd. (DermaZor) utilizes cannabis-enriched formulations and natural ingredients in its products.

Who is a notable member of Prestigio Ltd. (DermaZor)'s executive team?

Prof. Michael David serves as the Board Scientific Advisor for Prestigio Ltd. (DermaZor).

What business models does Prestigio Ltd. (DermaZor) employ?

Prestigio Ltd. (DermaZor) employs both B2C and B2B business models.

What are the target markets for Prestigio Ltd. (DermaZor)?

Prestigio Ltd. (DermaZor) targets global markets.

Team · 1

Prof. Michael David

Board Scientific Advisor

Sectors & technology